FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3904511000001104: Molipaxin 50mg/5ml oral liquid (Aventis Pharma) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18020701000001117 Molipaxin 50mg/5ml oral liquid (Aventis Pharma) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
65904501000001118 Molipaxin 50mg/5ml oral liquid (Sanofi) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Is a Trazodone 50mg/5ml oral solution sugar free true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has active ingredient Trazodone hydrochloride false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has manufactured dose form Conventional release oral solution false Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Is a Molipaxin true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has specific active ingredient Trazodone hydrochloride true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has active ingredient Trazodone true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has dispensed dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Has manufactured dose form Conventional release oral solution true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Is pack of False Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Inferred relationship Existential restriction modifier
Molipaxin 50mg/5ml oral liquid (Aventis Pharma) 120 ml Has AMP True Molipaxin 50mg/5ml oral liquid (Aventis Pharma) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start